The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's By Dennis Thompson HealthDay Reporter THURSDAY, Sept. 19, 2024 (HealthDay News) -- A specific class of diabetes drug appears to lower ...

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer's disease or Parkinson's disease, and a 30% reduced risk of ...

A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...

But these drugs might also protect brain health, researchers found. SGLT2 inhibitors are associated with a 20% reduced risk of Alzheimer’s disease or Parkinson’s disease, and a 30% reduced ...